ETFIQData as of Nov 18, 2026. · etfiq.com/funds/cstk

CSTK Fact Sheet: Invesco Comstock Contrarian Equity ETF

Share
$32.12
close, Nov 18, 2026

Over the year to Nov 18, 2026, CSTK returned +18.0% in total and charged 0.35% a year.

1-year total return
+18.0%
IWD +28.4% to Nov 18, 2026
Expense ratio
0.35%
a year
Net assets
$184m
on Nov 17, 2026
Net flow, last 5 trading days
+$332k
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

CSTK $11,802 +18.0% · IWD $12,841 +28.4% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−3.5%
3 months−4.9%
Year to date+11.8%
1 year+18.0%
Since launch+32.3%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Microsoft Corp4.08%
Alphabet Inc3.26%
Wells Fargo & Co3.00%
Philip Morris International Inc2.82%
Elevance Health Inc2.59%
Bank of America Corp2.58%
CVS Health Corp2.47%
Merck & Co Inc2.40%
Cisco Systems Inc2.38%
Amazon.com Inc2.34%

CSTK top ten by weight, 27.9% of the fund, of its 59 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Actively managed · First traded May 7, 2025 · Benchmark Russell 1000 Value Index, measured by IWD, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, CSTK Fact Sheet: Invesco Comstock Contrarian Equity ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/cstk/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/cstk.